This site is intended for US audiences only.
Full Prescribing Information
Visit Patient site
Indication
ONUREG® is indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following intensive induction chemotherapy and are not able to complete intensive curative therapy.
Please check back at a later time.
